BCI
ANAB icon

Brinker Capital Investments’s AnaptysBio ANAB Stock Holding History

Brinker Capital Investments’s Portfolio ANAB Stock Details ANAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$728K Sell
13,129
-1,568
-11% -$84.4K 0.01% 1298
2025
Q4 		$713K Buy
14,697
+958
+7% +$37.3K 0.01% 1426
2025
Q3 		$421K Buy
+13,739
New +$315K ﹤0.01% 1613

Other funds holding ANAB

EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Brinker Capital Investments's ANAB Position: Q1 2026 in Review

Brinker Capital Investments reduced its AnaptysBio (ANAB) stake by 11% in Q1 2026, selling an estimated $84.4K and leaving 13,129 shares worth $728K. The position accounts for 0.01% of the portfolio, ranked #1298.

Brinker Capital Investments first reported a position in ANAB in Q3 2025 and has held it in 3 quarters since. 207 funds tracked by Wall St. Rank hold ANAB as of Q1 2026.

  • Brinker Capital Investments held 13,129 shares of AnaptysBio worth $728K as of Q1 2026.
  • Brinker Capital Investments sold 1,568 AnaptysBio shares in Q1 2026, an estimated $84.4K.
  • AnaptysBio made up 0.01% of Brinker Capital Investments's portfolio in Q1 2026, its #1298 holding.
  • Brinker Capital Investments first reported a position in AnaptysBio in Q3 2025 and has held it in 3 quarters since.
  • 207 funds tracked by Wall St. Rank held AnaptysBio as of Q1 2026.

Based on Brinker Capital Investments's 13F filing for Q1 2026, filed 13 May 2026.